A DNA vaccine expressing dengue-4 virus premembrane (prM) and envelope (E) genes was produced by inserting these genes into a mammalian expression plasmid (pCI). Following a thorough screening, including confirmation of protein expression in vitro, a recombinant clone expressing these genes was selected and used to immunize BALB/c mice. After 3 immunizations all the animals produced detectable levels of neutralizing antibodies against dengue-4 virus. The cytokines levels and T cell proliferation, detected ex vivo from the spleen of the immunized mice, showed that our construction induced substantial immune stimulation after three doses. Even though the antibody levels, induced by our DNA vaccine, were lower than those obtained in mice immunized with dengue-4 virus the levels of protection were high with this vaccine. This observation is further supported by the fact that 80% of the vaccine immunized group was protected against lethal challenge. In conclusion, we developed a DNA vaccine employing the genes of the prM and E proteins from dengue-4 virus that protects mice against this virus.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vaccine.2010.10.078 | DOI Listing |
J Glob Infect Dis
November 2023
Department of Epidemiology NIMHANS, Bengaluru, Karnataka, India.
Introduction: Encephalitis is a major public health problem worldwide that causes huge emotional and economic loss to humanity. Encephalitis, being a serious illness, affects people of all ages. The aim is to describe the sociodemographic, clinical, etiological, and neuroimaging profile among 101 acute encephalitis syndrome (AES) patients visiting a tertiary neuro-specialty care hospital in India.
View Article and Find Full Text PDFJ Insect Physiol
December 2023
Departamento de Microbiologia, Imunologia e Parasitologia. Universidade Federal de Santa Catarina. Florianópolis, Brazil; Instituto Nacional de Ciência e Tecnologia em Entomologia Molecular. Brazil. Electronic address:
A detailed understanding of how host fitness changes in response to variations in microbe density (an ecological measure of disease tolerance) is an important aim of infection biology. Here, we applied dose-response curves to study Aedes aegypti survival upon exposure to different microbes. We challenged female mosquitoes with Listeria monocytogenes, a model bacterial pathogen, Dengue 4 virus and Zika virus, two medically relevant arboviruses, to understand the distribution of mosquito survival following microbe exposure.
View Article and Find Full Text PDFFront Microbiol
September 2022
Laboratory for Biodiversity Science, Department of Biomedical Engineering, School of Electronic Information Engineering, Xi'an Technological University, Xi'an, China.
There have been at least four types of dengue outbreaks in the past few years. The evolutionary characteristics of dengue viruses have aroused great concerns. The evolutionary characteristics of dengue 4 viruses are studied in the present study based on their base usage patterns and codon usage patterns.
View Article and Find Full Text PDFMicrobes Infect
February 2023
Laboratório de Entomologia I, Fiocruz Rondônia - Fundação Oswaldo Cruz, Lagoa, 76812-245, Porto Velho, Rondônia State, Brazil; Programa de Pós-Graduação em Biologia Experimental - PGBIOEXP, Fundação Universidade Federal de Rondônia - UNIR, BR-364, km 9.5, 76801-059, Porto Velho, Rondônia State, Brazil; Instituto Nacional de Epidemiologia da Amazônia Ocidental - INCT-EpiAmO, Lagoa, 76812-245, Porto Velho, Rondônia State, Brazil.
Although arbovirus transmission and identifying target vectors may provide a baseline for planning disease control strategies, there are many gaps in knowledge regarding these mosquitoes and viral species in urban, rural, or sylvatic habitats in the Brazilian Amazon. Our goal was to screen for dengue, chikungunya, and Zika viruses in synanthropic mosquitoes and with Flinders Technology Associates (FTA) cards using insect saliva. Mosquitoes were caught using ovitraps and aspirators in the city of Porto Velho, Rondônia, Brazil.
View Article and Find Full Text PDFInt J Pept Res Ther
September 2021
Department of Biotechnology, Saroj Institute of Technology & Management, Lucknow, Utter Pradesh India.
An immunoinformatics technique was used to predict a monovalent amide immunogen candidate capable of producing therapeutic antibodies as well as a potent immunogen candidate capable of acting as a universal vaccination against all dengue fever virus serotypes. The capsid protein is an attractive goal for anti-DENV due to its position in the dengue existence cycle. The widely accessible immunological data, advances in antigenic peptide prediction using reverse vaccinology, and the introduction of molecular docking in immunoinformatics have directed vaccine manufacturing.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!